Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
Drug Distribution: Plasma Protein Binding01:29

Drug Distribution: Plasma Protein Binding

Drugs predominantly attach to plasma proteins, with only a small percentage remaining unbound. The unbound portion can be calculated as one minus the bound fraction. Acidic drugs form large, inactive complexes by reversibly binding to plasma albumin, which prevents them from diffusing across biological barriers. These drug-protein complexes act as reservoirs for the drugs. As the concentration of unbound drugs decreases, these complexes quickly dissociate to release the free drug, maintaining...
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Early mobilization with or without cycloergometry in patients with septic shock in Intensive Care Unit: a randomized controlled trial.

Annals of intensive care·2026
Same author

Low thoracic skeletal muscle index is associated with negative outcomes in 244 patients with respiratory COVID-19.

Clinical nutrition (Edinburgh, Scotland)·2022
Same author

Prevalence and evaluation of oropharyngeal dysphagia in patients with severe acute respiratory syndrome coronavirus 2 infection in the intensive care unit.

The Journal of laryngology and otology·2022
Same author

Covid-19 severe hypoxemic pneumonia: A clinical experience using high-flow nasal oxygen therapy as first-line management.

Respiratory medicine and research·2021
Same author

Persistent swallowing disorders after extubation in mechanically ventilated patients in ICU: a two-center prospective study.

Annals of intensive care·2020
Same author

Association of transcription factor 7-like 2 gene (TCF7L2) polymorphisms with stress-related hyperglycaemia (SRH) in intensive care and resulting outcomes: The READIAB study.

Diabetes & metabolism·2019

Related Experiment Videos

[Albumin in sepsis].

F Tamion1

  • 1Service de réanimation médicale, CHU de Rouen, 1 rue de Germont, Rouen, France. fabienne.tamion@chu-rouen.fr

Annales Francaises D'Anesthesie Et De Reanimation
|August 3, 2010
PubMed
Summary

Human serum albumin, a key plasma protein, acts as an antioxidant. While its use in vascular collapse is debated, it may benefit specific critically ill patients by limiting oxidative damage.

Area of Science:

  • Biochemistry
  • Physiology

Context:

  • Human serum albumin (HSA) is the most abundant plasma protein, crucial for maintaining osmotic pressure and transporting ligands.
  • It possesses significant antioxidant properties due to a free thiol group at Cys-34, contributing to redox activity.

Purpose:

  • To review the multifaceted roles of human serum albumin, particularly its antioxidant functions and potential therapeutic applications in critical care.
  • To discuss the implications of hypoalbuminemia in intensive care units and the current evidence regarding albumin administration.

Summary:

  • HSA, a 66kD globular protein with 585 amino acids, plays vital roles including ligand binding, transport, and antioxidant defense.
  • Hypoalbuminemia is prevalent in critically ill patients, potentially stemming from reduced synthesis or increased loss.

Related Experiment Videos

  • While not superior to crystalloids for vascular collapse, HSA's antioxidant capacity suggests potential benefits in mitigating oxidative damage in specific patient groups.

    • Impact:

    • Albumin's antioxidant properties may offer therapeutic advantages in critically ill patients, particularly those with hypoalbuminemia.
    • Further research is essential to elucidate the precise mechanisms and confirm the benefits of albumin administration in specific intensive care unit populations.